%0 Journal Article
%T Adjuvant treatment in biliary tract cancer
%A Alessandro Rizzo
%A Andrea Palloni
%A Francesca Abbati
%A Giorgio Frega
%A Giovanni Brandi
%A Marzia Deserti
%A Simona Tavolari
%A Stefania De Lorenzo
%J SCIE-indexed Journal
%D 2019
%R 10.21037/23744
%X Biliary tract cancers (BTC) comprise a heterogeneous group of malignancies arising along the biliary tree with a low incidence and poor prognosis. BTC account for nearly 3% of all gastrointestinal cancers (1) and are classified according to anatomical location into intrahepatic cholangiocarcinoma (iCCA), perihilar cholangiocarcinoma, also known as Klatskin tumor (pCCA) and distal extrahepatic cholangiocarcinoma (eCCA). Despite having a different biological behavior and prognosis, ampullary and gallbladder cancers are grouped with cholangiocarcinoma (CCA) in some series
%U http://tcr.amegroups.com/article/view/23744/html